Publication Name	World Journal of Gastroenterology
Manuscript ID	1631
Country	China

Received	2012-12-24 19:47
Peer-Review Started	2012-12-24 21:15
To Make the First Decision	2013-01-24 18:46
Return for Revision	2013-01-25 17:09
Revised	2013-02-03 23:21
Second Decision	2013-02-07 09:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-02-07 10:15
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-04-24 14:50
Publish the Manuscript Online	2013-05-07 10:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	CD133: A cancer stem cells marker, is used in colorectal cancers
Manuscript Source	Invited Manuscript
All Author List	Fei Ren, Wei-Qi Sheng and Xiang Du
Funding Agency and Grant Number	Funding Agency Grant Number Clinical Key Discipline Fund by Ministry of Health 2010-2012 Chinese National Clinical Key Discipline 2011-2012 Shanghai Science and Technology Commission of Shanghai Municipality 10DJ1400500
Corresponding Author	Xiang Du, MD, PhD, Department of Pathology, Shanghai Cancer Center, Fudan University, 270 Dong An Road, Shanghai 200032, China. dx2008cn@yahoo.com.cn
Key Words	CD133; Colorectal cancer; Cancer stem cells; Prognosis; Chemoradiotherapy resistance
Core Tip	CD133 is not a reliable marker to identify the entire population of cancer stem cells (CSCs). However, the abundance of CD133 may be a good indicator of CSC identity and consistent with the biological characteristics of CSCs; The expression of CD133 is correlated to the poor survival; CD133(+) cells exhibit more chemoresistant behavior than CD133(-) cells; Whether CD133-targeting therapies can be a specific or efficient treatment for colorectal cancer has not been confirmed.
Publish Date	2013-05-07 10:53
Citation	Ren F, Sheng WQ, Du X. CD133: A cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol 2013; 19(17): 2603-2611
URL	http://www.wjgnet.com/1007-9327/full/v19/i17/2603.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i17.2603

Full Article (PDF)	WJG-19-2603.pdf
Manuscript File	1631-Review.doc
Answering Reviewers	1631-Answering reviewers.pdf
Copyright License Agreement	1631-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	1631-Language certificate.pdf
Peer-review Report	1631-Peer review.docx
Scientific Editor Work List	1631-Scientific editor work list.doc